Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY)Keiju Aokage, Shohei Koyama, Shogo Kumagai, et al.JTO Clinical and Research Reports|February 26, 2025
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in <i>EGFR</i>-Mutated Lung AdenocarcinomaYuji Uehara, Hiroki Izumi, Tetsuro Taki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 5, 2025
Translational analysis of NSD3 gene amplification in lung squamous cell carcinoma: Clinical and prognostic insights from histopathological analysis of patient samplesShugo Takahashi, Tetsuro Taki, Nobuyuki Nakamura, et al.Pathology International|August 17, 2023
The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lungTakehiko Tanaka, Shigeki Umemura, Tomohiro Miyoshi, et al.Cancer Science|June 2, 2023
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinomaYosuke Kagawa, Tokiko Nakai, Tetsuro Taki, et al.Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinomaYutaro Tamiya, Tokiko Nakai, Ayako Suzuki, et al.Cancer Immunology, Immunotherapy : CII|March 2, 2023
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinomaYu Tanaka, Tokiko Nakai, Ayako Suzuki, et al.British Journal of Cancer|July 16, 2025
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapyShunsuke A Sakai, Hidekazu Oyoshi, Masaki Nakamura, et al.The Journal of Experimental Medicine|January 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Meiting Yue, Shijie Tang, et al.Biorxiv : the Preprint Server for Biology|March 11, 2024
A Lung Cancer Mouse Model DatabaseLing Cai, Ying Gao, Ralph J DeBerardinis, et al.Pageof 6